Profile of:

Mirjam De Vries


Full name: Mirjam De Vries

Current country: Sweden

Membership level: Full

Type of membership: Member

Number of publications: 12

Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study (2018)
https://pubmed.ncbi.nlm.nih.gov/29195024/

C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis (2015)
https://pubmed.ncbi.nlm.nih.gov/25603416/

The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis (2010)
https://pubmed.ncbi.nlm.nih.gov/20132069/

Discovertebral (Andersson) lesions in severe ankylosing spondylitis: a study using MRI and conventional radiography (2010)
https://pubmed.ncbi.nlm.nih.gov/20496041/

pANCA, ASCA, and OmpC antibodies in patients with ankylosing spondylitis without inflammatory bowel disease (2010)
https://pubmed.ncbi.nlm.nih.gov/20810508/

Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation (2009)
https://pubmed.ncbi.nlm.nih.gov/19822712/

Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis (2009)
https://pubmed.ncbi.nlm.nih.gov/18375542/

Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis (2009)
https://pubmed.ncbi.nlm.nih.gov/19877087/

Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis (2009)
https://pubmed.ncbi.nlm.nih.gov/19404933/

Discovertebral (Andersson) lesions of the spine in ankylosing spondylitis revisited (2009)
https://pubmed.ncbi.nlm.nih.gov/19294478/

Inefficacy of infliximab in ankylosing spondylitis is correlated with antibody formation (2007)
https://pubmed.ncbi.nlm.nih.gov/17178760/

Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation (2007)
https://pubmed.ncbi.nlm.nih.gov/17472991/